[go: up one dir, main page]

US6458460B1 - Wound dressing - Google Patents

Wound dressing Download PDF

Info

Publication number
US6458460B1
US6458460B1 US09/254,323 US25432399A US6458460B1 US 6458460 B1 US6458460 B1 US 6458460B1 US 25432399 A US25432399 A US 25432399A US 6458460 B1 US6458460 B1 US 6458460B1
Authority
US
United States
Prior art keywords
fibres
wound
dressing
discrete
alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/254,323
Other languages
English (en)
Inventor
Bryan Griffiths
Elizabeth Jacques
Stephen Bishop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Convatec Technologies Inc
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10799482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US6458460(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BISHOP, STEPHEN, GRIFFITHS, BRYAN, JACQUES, ELIZABETH
Application granted granted Critical
Publication of US6458460B1 publication Critical patent/US6458460B1/en
Assigned to J.P. MORGAN EUROPE LIMITED reassignment J.P. MORGAN EUROPE LIMITED SECURITY AGREEMENT Assignors: CONVATEC INC.
Assigned to CONVATEC TECHNOLOGIES INC. reassignment CONVATEC TECHNOLOGIES INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRISTOL-MYERS SQUIBB COMPANY, CONVATEC, INC.
Assigned to CONVATEC INC. reassignment CONVATEC INC. RELEASE OF SECURITY INTEREST Assignors: J.P. MORGAN EUROPE LIMITED
Assigned to J.P. MORGAN EUROPE LIMITED reassignment J.P. MORGAN EUROPE LIMITED SECURITY AGREEMENT Assignors: CONVATEC TECHNOLOGIES INC.
Assigned to CONVATEC TECHNOLOGIES, INC. reassignment CONVATEC TECHNOLOGIES, INC. RELEASE OF SECURITY INTEREST AT 021901/0419 Assignors: J.P. MORGAN EUROPE LIMITED
Assigned to JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT reassignment JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: CONVATEC TECHNOLOGIES, INC.
Assigned to UNOMEDICAL A/S, CONVATEC TECHNOLOGIES, INC., UNOMEDICAL LIMITED, CONVATEC LIMITED reassignment UNOMEDICAL A/S RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: JPMORGAN CHASE BANK, N.A.
Assigned to WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT reassignment WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: 180 MEDICAL, INC., CONVATEC INC., CONVATEC TECHNOLOGIES INC., PRN MEDICAL SERVICES, LLC
Anticipated expiration legal-status Critical
Assigned to CONVATEC TECHNOLOGIES INC. reassignment CONVATEC TECHNOLOGIES INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: WILMINGTON TRUST (LONDON) LIMITED
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01034—Non-adhesive bandages or dressings characterised by a property
    • A61F13/01042—Absorbency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A61F13/069—Decubitus ulcer bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00217—Wound bandages not adhering to the wound
    • A61F2013/00229—Wound bandages not adhering to the wound with alginate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00727—Plasters means for wound humidity control
    • A61F2013/00748—Plasters means for wound humidity control with hydrocolloids or superabsorbers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/249921—Web or sheet containing structurally defined element or component
    • Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]
    • Y10T428/249962—Void-containing component has a continuous matrix of fibers only [e.g., porous paper, etc.]
    • Y10T428/249964—Fibers of defined composition
    • Y10T428/249965—Cellulosic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/27—Web or sheet containing structurally defined element or component, the element or component having a specified weight per unit area [e.g., gms/sq cm, lbs/sq ft, etc.]
    • Y10T428/273—Web or sheet containing structurally defined element or component, the element or component having a specified weight per unit area [e.g., gms/sq cm, lbs/sq ft, etc.] of coating
    • Y10T428/277—Cellulosic substrate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913—Rod, strand, filament or fiber
    • Y10T428/2933—Coated or with bond, impregnation or core
    • Y10T428/2936—Wound or wrapped core or coating [i.e., spiral or helical]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31551—Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
    • Y10T428/31591—Next to cellulosic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/603—Including strand or fiber material precoated with other than free metal or alloy
    • Y10T442/607—Strand or fiber material is synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/682—Needled nonwoven fabric
    • Y10T442/684—Containing at least two chemically different strand or fiber materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/682—Needled nonwoven fabric
    • Y10T442/684—Containing at least two chemically different strand or fiber materials
    • Y10T442/686—Containing polymeric and natural strand or fiber materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/69—Autogenously bonded nonwoven fabric
    • Y10T442/692—Containing at least two chemically different strand or fiber materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/696—Including strand or fiber material which is stated to have specific attributes [e.g., heat or fire resistance, chemical or solvent resistance, high absorption for aqueous compositions, water solubility, heat shrinkability, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/697—Containing at least two chemically different strand or fiber materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/60—Nonwoven fabric [i.e., nonwoven strand or fiber material]
    • Y10T442/697—Containing at least two chemically different strand or fiber materials
    • Y10T442/698—Containing polymeric and natural strand or fiber materials

Definitions

  • This invention relates a wound dressing and in particular a non-adherent wound dressing comprising fibrous material.
  • the invention also relates to a method of treating a wound comprising applying the dressing to a wound.
  • wound dressings comprise gauze, foams, sponges, cotton wads or other fibrous materials. Gauze and other fibrous materials absorb fluids by capillary action. Some absorbent fibres are capable of forming a gel on contact with exudate which can give the advantage of non-adherence to the wound. Such fibres when used alone in contact with a wound tend to preferentially absorb a particular type of exudate. In addition such fibres when used alone in contact with a wound tend to be capable of absorbing exudate at only one rate or in one rate pattern.
  • WO 96/10106 relates to fibres which are useful in wound dressings which comprise alginate co-spun with at least one water soluble species other than alginate.
  • the fibres although of composite type, are used alone and may not achieve optimum treatment of a particular wound.
  • the present invention provides a wound dressing comprising, in sheet form, a mixture of different types of gel forming fibres.
  • the wound dressing according to the invention may have the advantages that it provides good absorbency for a range of exudates and is also relatively inexpensive.
  • a moist wound environment may be created which has been found to be beneficial to wound healing.
  • the gel forming fibres for use in the present invention are hygroscopic fibres which upon the uptake of wound exudate become moist and slippery or gelatinous and thus reduce the tendancy for the surrounding fibres to adhere to the wound.
  • the gel forming fibres can be of the type which retain their structural integrity on absorbtion of exudate or can be of the type which lose their fibrous form and become a structureless gel or a solution on absorption of exudate.
  • the gel forming fibres are preferably spun sodium carboxymethylcellulose fibres, chemically modified cellulosic fibres, in particular carboxymethylated cellulose fibres as described in PCT WO/9312275 to Courtaulds Plc or GB93/01258 to Courtaulds Plc, pectin fibres, alginate fibres and particularly those as described in WO94/17227 to E. R. Squibb and Sons or EP 433354 to CV Laboratories Ltd or EP 476756 to CV Laboratories Ltd, chitosan fibres, hyaluronic acid fibres, or other polysaccharide fibres or fibres derived from gums.
  • the cellulosic fibres preferably have a degree of substitution of at least 0.05 carboxymethyl groups per glucose unit.
  • the production of solvent-spun cellulose fibres is described for example in U.S. Pat. Nos. 4,246,221 and 4,196,281 as well as in PCT WO/9312275 mentioned above.
  • the gel forming fibres for use in the present invention have an absorbency of either water or saline of at least 15 g/g as measured in the free swell absorbency method, more preferably at least 25 g/g or 50 g/g.
  • the degree of substitution of the gel forming fibre is preferably at least 0.2 carboxymethyl groups per glucose unit, more preferably between 0.3 and 0.5.
  • the tenacity of the fibre is preferably in the range 25-15 cN/tex.
  • the gel forming fibres are preferably mixed to give a dressing comprising fibres of different absorbencies and also different absorbency rates and profiles.
  • the dressing may comprise other fibres such as textile fibres which can be natural or synthetic but are preferably cellulosic fibres for example viscose rayon, multi-limbed viscose, cotton, or regenerated cellulose or fibres having a higher absorbency than most textile fibres such as the multi-limbed cellulose fibres as described in EP-A-301874.
  • textile fibres absorb liquids by capilliary action and are not hygroscopic this means that their absobancies as measured by the free swell absorbency test are low such as less than 1 gram of liquid per gram of fibre.
  • the dressing comprises a blend of gel forming alginate fibres and cellulosic fibres in the range of 50% to 95% of alginate fibres and 5% to 50% of modified cellulose fibres by weight.
  • the dressing comprises a blend of fibres in the range of 65% to 80% alginate fibres and 20% to 35% modified cellulose fibres by weight and most preferably 30% modified cellulose fibres and 70% alginate fibres by weight.
  • the gel forming fibres suitable for use in the present invention can be processed using conventional textile machinery, for example by the staple route including cutting, carding and if desired crimping, drafting and spinning.
  • the wound dressing of the present invention may be in sheet form and may be made by intimately mixing the gel forming fibres, for example by carding, air-laying or needle punching the fibres together to form a web of mixed fibres.
  • the wound dressing of the present invention may be made by spinning or twisting the gel forming fibres together to form a yarn and then knitting or weaving the yarn to form a bandage or stocking.
  • the wound dressing of the present invention may be in the form of swabs, wound pads, wadding ribbons, sponges, nets and bandages with the fibrous layer being one of many layers and may be used as a primary or secondary dressing especially in the treatment of leg ulcers.
  • Various optional ingredients can also be included in the final composition such as preservatives and small amounts of pharmacologically active ingredients.
  • an antibiotic or antimicrobial agent such as metronidazole, silver sulphadiazine, neomycin or penicillin and antiseptic agent such as povidone iodine and antiinflammatory agent such as hydrocortisone or triamcinolone acteonide or a skin protective agent such as a zinc oxide can be included.
  • an antibiotic or antimicrobial agent such as metronidazole, silver sulphadiazine, neomycin or penicillin and antiseptic agent such as povidone iodine and antiinflammatory agent such as hydrocortisone or triamcinolone acteonide or a skin protective agent such as a zinc oxide
  • metronidazole such as metronidazole, silver sulphadiazine, neomycin or penicillin
  • antiseptic agent such as povidone iodine
  • antiinflammatory agent such as hydrocortis
  • a dressing according to the invention was made by cutting fibres to a staple length of approximately 50 mm.
  • the alginate fibres were of the type described in EP 43 354 or EP 476 756 to CV Laboratories Ltd and sold as a fibrous dressing in the product KALTOSTAT ex ConvaTec and the cellulose fibres were of the type described in WO93/12275 to Courtaulds and sold as a fibrous dressing in the product AQUACEL ex ConvaTec.
  • the fibres were then separately weighed and crimped.
  • the fibres were then fed into an opening machine in the ratio 70% alginate fibre and 30% modified cellulose fibre to produce opened mixed fibre.
  • the mixture was then fed to a hopper of a delivery device set to deliver the mixture to a carding machine so that it yielded carded web in the density range 70 to 240 gsm. From the carding machine the fibre web was taken and cross-lapped prior to being needle punched and rolled-up. The resulting product was a homogeneous blend of fibres that was soft to the touch and of good integrity.
  • the fluid uptake of a dressings according to the invention was measured by immersing the dressings totally in a bath of Solution A or of water for five minutes total immersion time and then removing the dressings, allowing them to drain for 30 seconds and then weighing. Fluid uptake was measured for a dressing (Dressing A) according to example 1 above, a dressing (Dressing B) prepared by the method of Example 1 using the fibres of Example 1 except that the ratio of alginate to cellulosic fibres was 60% alginate to 40% modified cellulose and as a control a dressing containing 100% modified cellulose fibres as used in Example 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
US09/254,323 1996-09-05 1997-09-05 Wound dressing Expired - Lifetime US6458460B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9618565.7A GB9618565D0 (en) 1996-09-05 1996-09-05 Wound dressing
PCT/EP1997/004927 WO1998009590A1 (fr) 1996-09-05 1997-09-05 Pansement

Publications (1)

Publication Number Publication Date
US6458460B1 true US6458460B1 (en) 2002-10-01

Family

ID=10799482

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/254,323 Expired - Lifetime US6458460B1 (en) 1996-09-05 1997-09-05 Wound dressing

Country Status (12)

Country Link
US (1) US6458460B1 (fr)
EP (1) EP0927013B1 (fr)
JP (1) JP2000517226A (fr)
CN (1) CN1303955C (fr)
AT (1) ATE233525T1 (fr)
CA (1) CA2264584C (fr)
DE (1) DE69719524T2 (fr)
DK (1) DK0927013T3 (fr)
ES (1) ES2192695T3 (fr)
GB (1) GB9618565D0 (fr)
IL (1) IL128637A0 (fr)
WO (1) WO1998009590A1 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050101900A1 (en) * 2000-11-03 2005-05-12 Yimin Qin Polysaccharide fibres
US20050152955A1 (en) * 2003-12-16 2005-07-14 Akhave Jay R. Electrostatically self-assembled antimicrobial coating for medical applications
US20060211972A1 (en) * 2003-03-28 2006-09-21 Brian Nielsen Wound dressing
US20070053960A1 (en) * 2005-08-31 2007-03-08 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
EP1787663A1 (fr) * 2005-11-21 2007-05-23 The Procter and Gamble Company Couche d'acquisition de liquide destinée à des articles absorbants
WO2012142879A1 (fr) 2011-04-20 2012-10-26 佛山市优特医疗科技有限公司 Pansement ayant des propriétés bactériostatiques et hygroscopiques
US20140323999A1 (en) * 2011-12-01 2014-10-30 Convatec Technologies Inc. Wound dressing for use in vacuum therapy
US20150044267A1 (en) * 2009-12-24 2015-02-12 Liberman Distributing and Manufacturing Co., d/b/a Lidco Products ("Lidco") Advanced fabric technology and filters
WO2015096543A1 (fr) 2013-12-25 2015-07-02 佛山市优特医疗科技有限公司 Pansement contenant un tissu à trois couches et procédé de fabrication d'un pansement
CN106510948A (zh) * 2016-10-27 2017-03-22 北京吉原生物科技有限公司 一种肛门病术后护理敷料
US10179074B2 (en) 2012-07-16 2019-01-15 Medline Industries, Inc. Alginate wound dressing and method of making the same
US11096829B2 (en) * 2015-05-07 2021-08-24 Kci Licensing, Inc. Controlled release iodine structure for use with wound care

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510475A (ja) * 1999-09-27 2003-03-18 ビーエイチケー・ホールディング・リミテッド 吸収性ファブリック
GB2370226A (en) * 2000-09-21 2002-06-26 Acordis Speciality Fibres Ltd Wound dressing
GB0107655D0 (en) * 2001-03-27 2001-05-16 Bristol Myers Squibb Co Wound dressing
CN100339135C (zh) * 2005-05-13 2007-09-26 褚省吾 一种中空醋酸纤维抗菌型水凝胶敷料及其制备
WO2012092812A1 (fr) * 2011-01-05 2012-07-12 佛山市优特医疗科技有限公司 Pansement de plaie antibactérien, absorbant l'humidité et donneur d'ion calcium
WO2012092813A1 (fr) * 2011-01-07 2012-07-12 佛山市优特医疗科技有限公司 Pansement de plaie avec absorption élevée d'humidité et pouvant être enlevé intégralement
CN104024498B (zh) * 2011-11-01 2017-08-22 布莱特维克公司 伤口敷料以及可用于伤口敷料中的线
GB2512841B (en) 2013-04-08 2020-07-15 Brightwake Ltd Absorbent wound dressings
CN103655046B (zh) 2013-12-03 2016-02-03 佛山市优特医疗科技有限公司 一种具有三层结构的伤口敷料及其制备方法
CN115198413B (zh) * 2022-07-06 2023-05-26 武汉纺织大学 氧化粘胶纤维包芯纱止血材料及其制备方法

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328329A1 (de) * 1992-08-26 1994-03-03 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
EP0651983A1 (fr) * 1993-10-05 1995-05-10 Bristol-Myers Squibb Company Pausement de forme modifiable
US5445826A (en) * 1988-06-28 1995-08-29 Cibus Pharmaceutical, Inc. Delivery system containing a gel-forming dietary fiber and a drug
EP0691133A1 (fr) * 1994-07-05 1996-01-10 The Procter & Gamble Company Matériau gélifiant absorbant contenant un mélange sec d'au moins deux catégories de particules formant un hydrogel et procédé de préparation de ce dernier
WO1996010106A1 (fr) * 1994-09-29 1996-04-04 Innovative Technologies Limited Fibres
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
WO1998046818A1 (fr) * 1997-04-11 1998-10-22 Bristol-Myers Squibb Company Pansements tricotes et procede de fabrication de ces derniers
US6075117A (en) * 1998-12-21 2000-06-13 E.I. Dupont De Nemours & Company Process for the hydrolysis of adiponitrile and the production of nylon 6,6 using dicarboxylic acids as the sole catalyst
US6153214A (en) * 1996-09-05 2000-11-28 Tencel Limited Wound dressing and manufacture thereof
US9153214B2 (en) 2012-10-02 2015-10-06 Gustav Pirazzi & Comp. Kg Shoulder rest

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196281A (en) 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
US4246221A (en) 1979-03-02 1981-01-20 Akzona Incorporated Process for shaped cellulose article prepared from a solution containing cellulose dissolved in a tertiary amine N-oxide solvent
IT1194952B (it) 1980-06-26 1988-09-28 Italtractor Procedimento e mezzi per il riempimento e la chiusura del serbatoio di lubrificante previsto nel perno delle coppie rotoidali lubrificate in particolare nei perni delle maglie dei cingoli e deir ulli per mezzi cingolati
GB2208277B (en) 1987-07-30 1991-11-13 Courtaulds Plc Cellulosic fibre
CN1023294C (zh) * 1990-01-09 1993-12-29 汕头市康孚牙科材料厂 一种治疗伤口的外科敷料及其制备工艺
GB9020278D0 (en) 1990-09-17 1990-10-31 Britcair Ltd Alginate fabric
GB9126193D0 (en) 1991-12-10 1992-02-12 Courtaulds Plc Cellulosic fibres
CZ186995A3 (en) 1993-01-20 1996-01-17 Squibb & Sons Inc Fibers

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5445826A (en) * 1988-06-28 1995-08-29 Cibus Pharmaceutical, Inc. Delivery system containing a gel-forming dietary fiber and a drug
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
DE4328329A1 (de) * 1992-08-26 1994-03-03 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
EP0651983A1 (fr) * 1993-10-05 1995-05-10 Bristol-Myers Squibb Company Pausement de forme modifiable
EP0691133A1 (fr) * 1994-07-05 1996-01-10 The Procter & Gamble Company Matériau gélifiant absorbant contenant un mélange sec d'au moins deux catégories de particules formant un hydrogel et procédé de préparation de ce dernier
WO1996010106A1 (fr) * 1994-09-29 1996-04-04 Innovative Technologies Limited Fibres
US6153214A (en) * 1996-09-05 2000-11-28 Tencel Limited Wound dressing and manufacture thereof
WO1998046818A1 (fr) * 1997-04-11 1998-10-22 Bristol-Myers Squibb Company Pansements tricotes et procede de fabrication de ces derniers
US6075117A (en) * 1998-12-21 2000-06-13 E.I. Dupont De Nemours & Company Process for the hydrolysis of adiponitrile and the production of nylon 6,6 using dicarboxylic acids as the sole catalyst
US9153214B2 (en) 2012-10-02 2015-10-06 Gustav Pirazzi & Comp. Kg Shoulder rest

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229689B2 (en) * 2000-11-03 2007-06-12 Ssl International Polysaccharide fibres
US20050101900A1 (en) * 2000-11-03 2005-05-12 Yimin Qin Polysaccharide fibres
US20060211972A1 (en) * 2003-03-28 2006-09-21 Brian Nielsen Wound dressing
US20050152955A1 (en) * 2003-12-16 2005-07-14 Akhave Jay R. Electrostatically self-assembled antimicrobial coating for medical applications
US20070053960A1 (en) * 2005-08-31 2007-03-08 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
US8951551B2 (en) 2005-08-31 2015-02-10 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
US9273419B2 (en) 2005-11-21 2016-03-01 The Procter & Gamble Company Fluid acquisition layer
EP1787663A1 (fr) * 2005-11-21 2007-05-23 The Procter and Gamble Company Couche d'acquisition de liquide destinée à des articles absorbants
US20070118087A1 (en) * 2005-11-21 2007-05-24 The Procter & Gamble Company Fluid acquisition layer
WO2007057869A3 (fr) * 2005-11-21 2007-08-16 Procter & Gamble Couche d’acquisition de fluide
US10182946B2 (en) * 2009-12-24 2019-01-22 Liberman Distributing And Manufacturing Co. Advanced fabric technology and filters
US20150044267A1 (en) * 2009-12-24 2015-02-12 Liberman Distributing and Manufacturing Co., d/b/a Lidco Products ("Lidco") Advanced fabric technology and filters
WO2012142879A1 (fr) 2011-04-20 2012-10-26 佛山市优特医疗科技有限公司 Pansement ayant des propriétés bactériostatiques et hygroscopiques
US20140323999A1 (en) * 2011-12-01 2014-10-30 Convatec Technologies Inc. Wound dressing for use in vacuum therapy
US10968543B2 (en) 2011-12-01 2021-04-06 Convatec Technologies Inc. Wound dressing for use in vacuum therapy
US10179074B2 (en) 2012-07-16 2019-01-15 Medline Industries, Inc. Alginate wound dressing and method of making the same
WO2015096543A1 (fr) 2013-12-25 2015-07-02 佛山市优特医疗科技有限公司 Pansement contenant un tissu à trois couches et procédé de fabrication d'un pansement
US11096829B2 (en) * 2015-05-07 2021-08-24 Kci Licensing, Inc. Controlled release iodine structure for use with wound care
CN106510948A (zh) * 2016-10-27 2017-03-22 北京吉原生物科技有限公司 一种肛门病术后护理敷料

Also Published As

Publication number Publication date
IL128637A0 (en) 2000-01-31
EP0927013A1 (fr) 1999-07-07
CN1303955C (zh) 2007-03-14
GB9618565D0 (en) 1996-10-16
DE69719524T2 (de) 2004-02-19
CA2264584A1 (fr) 1998-03-12
EP0927013B1 (fr) 2003-03-05
JP2000517226A (ja) 2000-12-26
AU716252B2 (en) 2000-02-24
DK0927013T3 (da) 2003-04-22
AU4622197A (en) 1998-03-26
ATE233525T1 (de) 2003-03-15
CN1235533A (zh) 1999-11-17
CA2264584C (fr) 2006-06-13
DE69719524D1 (de) 2003-04-10
ES2192695T3 (es) 2003-10-16
WO1998009590A1 (fr) 1998-03-12

Similar Documents

Publication Publication Date Title
US6458460B1 (en) Wound dressing
US6471982B1 (en) Wound dressing
AU719928B2 (en) Knitted wound dressings and method for making same
EP0680344B1 (fr) Pansements pour blessures
AU711723B2 (en) Composite fibres, wound dressings incorporating such fibres and a method for making same
US5914124A (en) Alginate fibre, process for the preparation thereof and use
Parikh et al. Carboxymethylated Cotton for Moist Wound Healing.
AU716252C (en) Wound dressing
WO2021079126A1 (fr) Matériau antimicrobien
CZ76199A3 (cs) Obvaz na rány
NZ332977A (en) Knitted wound dressing comprising gel-forming fibres
MXPA98008311A (en) Composite fibers, wood bandage that includes such fibers and a method to manufacture lasmis

Legal Events

Date Code Title Description
AS Assignment

Owner name: BRISTOL-MYERS SQUIBB COMPANY, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GRIFFITHS, BRYAN;JACQUES, ELIZABETH;BISHOP, STEPHEN;REEL/FRAME:009910/0694

Effective date: 19990407

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: J.P. MORGAN EUROPE LIMITED, UNITED KINGDOM

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONVATEC INC.;REEL/FRAME:021371/0796

Effective date: 20080801

Owner name: J.P. MORGAN EUROPE LIMITED,UNITED KINGDOM

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONVATEC INC.;REEL/FRAME:021371/0796

Effective date: 20080801

AS Assignment

Owner name: CONVATEC TECHNOLOGIES INC., NEVADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRISTOL-MYERS SQUIBB COMPANY;CONVATEC, INC.;REEL/FRAME:021754/0611

Effective date: 20081027

Owner name: CONVATEC TECHNOLOGIES INC.,NEVADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRISTOL-MYERS SQUIBB COMPANY;CONVATEC, INC.;REEL/FRAME:021754/0611

Effective date: 20081027

AS Assignment

Owner name: CONVATEC INC., NEW JERSEY

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:J.P. MORGAN EUROPE LIMITED;REEL/FRAME:021890/0786

Effective date: 20081028

Owner name: CONVATEC INC.,NEW JERSEY

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:J.P. MORGAN EUROPE LIMITED;REEL/FRAME:021890/0786

Effective date: 20081028

AS Assignment

Owner name: J.P. MORGAN EUROPE LIMITED, UNITED KINGDOM

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONVATEC TECHNOLOGIES INC.;REEL/FRAME:021901/0419

Effective date: 20081028

Owner name: J.P. MORGAN EUROPE LIMITED,UNITED KINGDOM

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONVATEC TECHNOLOGIES INC.;REEL/FRAME:021901/0419

Effective date: 20081028

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: CONVATEC TECHNOLOGIES, INC., NEVADA

Free format text: RELEASE OF SECURITY INTEREST AT 021901/0419;ASSIGNOR:J.P. MORGAN EUROPE LIMITED;REEL/FRAME:025580/0879

Effective date: 20101223

AS Assignment

Owner name: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT, TE

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONVATEC TECHNOLOGIES, INC.;REEL/FRAME:025591/0856

Effective date: 20101222

Owner name: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT, TEXAS

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONVATEC TECHNOLOGIES, INC.;REEL/FRAME:025591/0856

Effective date: 20101222

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: CONVATEC TECHNOLOGIES, INC., NEVADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:040543/0357

Effective date: 20161031

Owner name: CONVATEC LIMITED, UNITED KINGDOM

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:040543/0357

Effective date: 20161031

Owner name: UNOMEDICAL LIMITED, UNITED KINGDOM

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:040543/0357

Effective date: 20161031

Owner name: UNOMEDICAL A/S, DENMARK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:040543/0357

Effective date: 20161031

AS Assignment

Owner name: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT, UNITED KINGDOM

Free format text: SECURITY AGREEMENT;ASSIGNORS:CONVATEC INC.;CONVATEC TECHNOLOGIES INC.;180 MEDICAL, INC.;AND OTHERS;REEL/FRAME:040552/0227

Effective date: 20161031

Owner name: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL A

Free format text: SECURITY AGREEMENT;ASSIGNORS:CONVATEC INC.;CONVATEC TECHNOLOGIES INC.;180 MEDICAL, INC.;AND OTHERS;REEL/FRAME:040552/0227

Effective date: 20161031

AS Assignment

Owner name: CONVATEC TECHNOLOGIES INC., NEVADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST (LONDON) LIMITED;REEL/FRAME:050831/0001

Effective date: 20191024